Who Exports Griseofulvin from India — 188 Suppliers Behind a $36.1M Market
India's griseofulvin export market is supplied by 188 active exporters who collectively shipped $36.1M across 1,084 shipments. LINCOLN PHARMACEUTICALS LTD leads with a 62.0% market share, followed by MEDOPHARM and LEBEN LABORATORIES PRIVATE LIMITED. The top 5 suppliers together control 76.6% of total export value, reflecting a concentrated market structure.
Top Griseofulvin Exporters from India — Ranked by Export Value
LINCOLN PHARMACEUTICALS LTD is the leading griseofulvin exporter from India, holding a 62.0% share of the $36.1M market across 1,084 shipments from 188 exporters. The top 5 suppliers — LINCOLN PHARMACEUTICALS LTD, MEDOPHARM, LEBEN LABORATORIES PRIVATE LIMITED, CIPLA LIMITED, USV PRIVATE LIMITED — collectively control 76.6% of total export value, indicating a highly concentrated market. Individual shares are: LINCOLN PHARMACEUTICALS LTD (62.0%), MEDOPHARM (4.2%), LEBEN LABORATORIES PRIVATE LIMITED (4.0%), CIPLA LIMITED (3.5%), USV PRIVATE LIMITED (2.8%).
Top Griseofulvin Exporters from India
Ranked by export value · 188 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | LINCOLN PHARMACEUTICALS LTD GRISEOFULVIN TABLETS 500 MG BP (DERMOFULGRISEOFULVIN TAB 500MG BP (DERMOFULVIN-FGRISEOFULVIN TABLETS BP 500 MG NOS | $22.4M | 3 | 62.0% |
| 2 | MEDOPHARM GRISEOFULVIN TABLETS 500 MG BP (DERMOFULGRISEOFULVIN TAB 500MG BP (DERMOFULVIN-FGRISEOFULVIN TABLETS BP 500MG (20000 X 1 | $1.5M | 10 | 4.2% |
| 3 | LEBEN LABORATORIES PRIVATE LIMITED AGOFULVIN TABLETS(GRISEOFULVIN TABLETS BPHARMACEUTICAL PRODUCTS - GRISEOFULVIN TABLETS BP 500MGGRISEOFULVIN TABLET 500 MG BP 10'S X 10 | $1.5M | 10 | 4.0% |
| 4 | CIPLA LIMITED | $1.3M | 1 | 3.5% |
| 5 | USV PRIVATE LIMITED | $1.0M | 1 | 2.8% |
| 6 | AGOG PHARMA LIMITED GRISEOFULVIN TABLETS 500 MG BP (DERMOFULGRISEOFULVIN TAB 500MG BP (DERMOFULVIN-FGRISEOFULVIN TABLETS BP 500MG (20000 X 1 | $728.8K | 2 | 2.0% |
| 7 | PRASHI PHARMA PRIVATE LIMITED GRISEOFULVIN TABLETS B.P. 500 MG EACH UNGRISEOFULVIN 250MG TABS - PACK:5X10X10GRISEOFULVINA GRISEOFULVIN TABLETS BP 500 MG | $720.8K | 3 | 2.0% |
| 8 | BAL PHARMA LIMITED GRISEOFULVIN TABLETS B.P. 500 MG EACH UNGRISEOFULVIN 250MG TABS - PACK:5X10X10GRISEOFULVINA GRISEOFULVIN TABLETS BP 500 MG | $634.0K | 3 | 1.8% |
| 9 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED GRISEOFULVIN TABLETS 500 MG BP (DERMOFULGRISEOFULVIN TAB 500MG BP (DERMOFULVIN-FGRISEOFULVIN TABLETS BP 500MG (20000 X 1 | $474.6K | 3 | 1.3% |
| 10 | LINCOLN PHARMACEUTICALS LIMITED GRISEOFULVIN TABLETS 500 MG BP (DERMOFULGRISEOFULVIN TAB 500MG BP (DERMOFULVIN-FGRISEOFULVIN TABLETS BP 500 MG NOS | $379.3K | 2 | 1.1% |
| 11 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $318.5K | 1 | 0.9% |
| 12 | ANGEL BIOGENICS PRIVATE LIMITED | $316.9K | 2 | 0.9% |
| 13 | STRIDES PHARMA SCIENCE LIMITED | $309.9K | 1 | 0.9% |
| 14 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED | $241.6K | 4 | 0.7% |
| 15 | TRENDS PHARMA PVT LTD GRILLE TABLETS GRISEOFULVIN TABLETS BP (GRILLE TABLETS GRISEOFULVIN TABLETS BP | $229.5K | 1 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Griseofulvin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| LINCOLN PHARMACEUTICALS LTD | Not Listed | Yes | Yes | Not verified | EU GMP certification obtained in May 2020. |
| CIPLA LIMITED | Approved | Yes | Yes | Not verified | FDA-approved manufacturer with WHO-GMP and EU GMP certifications. |
| AMNEAL PHARMACEUTICALS PRIVATE LIMITED | Approved | Yes | Yes | Not verified | FDA-approved manufacturer with WHO-GMP and EU GMP certifications. |
| LUPIN LIMITED | Approved | Yes | Yes | Not verified | FDA-approved manufacturer with WHO-GMP and EU GMP certifications. |
| MICRO LABS LIMITED | Approved | Yes | Yes | Not verified | FDA-approved manufacturer with WHO-GMP and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 5 leading Griseofulvin exporters from India. 4 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 5 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Griseofulvin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and bulk drugs. Notable firms include A.R. Life Sciences, which manufactures a wide range of APIs for various therapeutic areas. The presence of such companies underscores Hyderabad's pivotal role in the bulk drug sector, making it a strategic location for sourcing Griseofulvin APIs.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Vadodara, in particular, is home to numerous pharmaceutical companies specializing in formulations and biogenerics. (mediaindia.eu) Companies like Alembic Pharmaceuticals, headquartered in Vadodara, manufacture and market a range of pharmaceutical products, including APIs and formulations. This region's focus on formulations positions it as a key area for sourcing finished Griseofulvin products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a significant export gateway for pharmaceutical products. Mumbai, being a major port city, facilitates the export of pharmaceuticals to various international markets. Companies like Formel Labs, with facilities in Mumbai and Hyderabad, are committed to producing safe and effective medicines, ensuring quality at every stage from sourcing raw materials to final production. The strategic location and infrastructure of this region make it a crucial hub for exporting Griseofulvin formulations.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, primarily due to favorable tax incentives. This zone attracts numerous pharmaceutical companies seeking cost-effective production solutions. While not directly linked to Griseofulvin production, the region's growth highlights the importance of tax incentives in pharmaceutical manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: While Lincoln Pharmaceuticals Ltd dominates Griseofulvin exports, consider engaging with other suppliers such as Medopharm and Leben Laboratories Private Limited to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize Hyderabad's expertise in bulk drug production for sourcing APIs and Ahmedabad-Vadodara's capabilities in formulations for finished products.
- Optimize Export Logistics: Capitalize on the Mumbai-Thane-Raigad region's infrastructure to streamline export processes and reduce lead times.
- Monitor Regulatory Compliance: Ensure all suppliers adhere to international quality standards and regulatory requirements to maintain product integrity and market access.
By strategically engaging with these pharmaceutical clusters and suppliers, TransData Nexus can enhance its supply chain resilience and meet the growing demand for Griseofulvin in key markets.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Griseofulvin exporters from India
Lincoln Pharmaceuticals Limited — Lincoln Pharmaceuticals merges with Lincoln Parenteral Limited
The National Company Law Tribunal (NCLT) approved the amalgamation of Lincoln Parenteral Limited into Lincoln Pharmaceuticals Limited, consolidating operations to enhance efficiency and market reach. - IMPACT: This merger is expected to streamline production processes, potentially increasing Griseofulvin export capacity.
Impact: This merger is expected to streamline production processes, potentially increasing Griseofulvin export capacity.
Cipla Limited — Cipla acquires Ivia Beaute's cosmetics and personal care division
Cipla Limited acquired the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd for ₹130 crore, aiming to diversify its product portfolio. - IMPACT: While this acquisition focuses on cosmetics, it may allow Cipla to reallocate resources towards pharmaceutical production, potentially affecting Griseofulvin exports.
Impact: While this acquisition focuses on cosmetics, it may allow Cipla to reallocate resources towards pharmaceutical production, potentially affecting Griseofulvin exports.
Cipla Limited — Cipla acquires InvaGen and Exelan Pharmaceuticals for $555 million
Cipla Limited acquired U.S.-based InvaGen Pharmaceuticals and Exelan Pharmaceuticals for $555 million, expanding its presence in the U.S. market. - IMPACT: This acquisition enhances Cipla's manufacturing capabilities, potentially increasing Griseofulvin exports to the U.S.
Impact: This acquisition enhances Cipla's manufacturing capabilities, potentially increasing Griseofulvin exports to the U.S.
Common Questions — Griseofulvin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which griseofulvin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, LINCOLN PHARMACEUTICALS LTD leads with 25 recorded shipments worth $22.4M. MEDOPHARM (34 shipments) and LEBEN LABORATORIES PRIVATE LIMITED (74 shipments) are also established high-volume exporters.
Q How many griseofulvin manufacturers are there in India?
India has 188 active griseofulvin exporters with a combined export market of $36.1M across 1,084 shipments to 97 countries. The top 5 suppliers hold 76.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for griseofulvin from India?
Average FOB unit price: $27.20 per unit, ranging from $0.01 to $1250.00. Average shipment value: $33.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 188 verified Indian exporters of Griseofulvin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,084 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 97 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,084 Verified Shipments
188 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists